These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 4688656)
21. Immune response of mice to concanavalin A-coated EL 4 leukemia. Martin WJ; Wunderlich JR Natl Cancer Inst Monogr; 1972 Dec; 35():295-9. PubMed ID: 4679048 [No Abstract] [Full Text] [Related]
22. Natural cytotoxic reactivity of rat lymphocytes against gross virus-induced tumor cell lines as measured by [125I]iododeoxyuridine and tritiated proline microcytotoxicity assays. Oldham RK; Ortaldo JR; Herberman RB Cancer Res; 1977 Dec; 37(12):4467-74. PubMed ID: 922735 [TBL] [Abstract][Full Text] [Related]
23. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570). Liepins A; Nowicky JW Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312 [TBL] [Abstract][Full Text] [Related]
24. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo. Brawand P; Biasi G; Horvath C; Cerottini JC; MacDonald HR J Immunol; 1998 Feb; 160(4):1659-65. PubMed ID: 9469422 [TBL] [Abstract][Full Text] [Related]
25. Tumor cell-triggered macrophage-mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. I. Characterization of the cell components for induction of suppression. Ting CC; Rodrigues D J Natl Cancer Inst; 1982 Oct; 69(4):867-72. PubMed ID: 6214653 [TBL] [Abstract][Full Text] [Related]
26. Regulatory role of T suppressor cells on natural and induced humoral anti-tumor reactivity of C57BL/6J mice. Colnaghi MI; Ménard S J Immunol; 1980 Jun; 124(6):2530-5. PubMed ID: 6966292 [No Abstract] [Full Text] [Related]
27. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors. Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385 [No Abstract] [Full Text] [Related]
28. [Blocking activity in vitro and biological effect of IgG (7S-antibodies) isolated from the spleen cells and serum of mice with progressive Rauscher leukemia]. Ter-Grigorov VS; Dzagurov SG; Shevelev BI Biull Eksp Biol Med; 1974 Dec; 78(12):55-8. PubMed ID: 4441659 [No Abstract] [Full Text] [Related]
29. Heterogenous populations of cytotoxic cells in the peritoneal cavity of BALB/c mice immunized with allogeneic EL4 leukemia cells. Zighelboim J; Bonavida B; Fahey JL Cell Immunol; 1974 May; 12(2):280-9. PubMed ID: 4458965 [No Abstract] [Full Text] [Related]
30. Increase in sensitivity of the microcytotoxicity assay by T cell growth factor (IL-2)-containing preparations. Indrová M; Bubeník J Folia Biol (Praha); 1984; 30(1):43-9. PubMed ID: 6609090 [TBL] [Abstract][Full Text] [Related]
31. Functional clonal deletion and suppression as complementary mechanisms operative in adult hapten-induced cytotoxic T cell tolerance. Good MF; Nossal GJ J Immunol; 1983 Dec; 131(6):2662-9. PubMed ID: 6227660 [TBL] [Abstract][Full Text] [Related]
32. Cytotoxic lymphocytes in the absence of detectable antibody. Berke G; Amos DB Nat New Biol; 1973 Apr; 242(121):237-9. PubMed ID: 4540806 [No Abstract] [Full Text] [Related]
33. Development of long-term cell lines and lymphoid clones reactive against murine and human tumors: a new approach to the adoptive immunotherapy of cancer. Rosenberg SA; Eberlein TJ; Grimm EA; Lotze MT; Mazumder A; Rosenstein M Surgery; 1982 Aug; 92(2):328-36. PubMed ID: 6980492 [TBL] [Abstract][Full Text] [Related]
34. [Detection of the cytotoxic effect of tumor cells against the targets of normal killers]. Fuks BB; Zedginidze MS; Spirande IV; Kogarko IN; Sterlina AG Biull Eksp Biol Med; 1981 Sep; 92(9):342-5. PubMed ID: 7295991 [TBL] [Abstract][Full Text] [Related]
35. [Effect of the Friend leukemia virus on lymphocyte subpopulations in the mouse]. Jezzi T; Premrov MG; Del Gobbo V; Garaci E Ann Ist Super Sanita; 1982; 18(3):513-5. PubMed ID: 6230037 [No Abstract] [Full Text] [Related]
36. Effects of cholera toxin on the lymphoid system. III. In vivo generation of cytotoxic lymphocytes. Tsuru S; Nomoto K; Oka M; Zinnaka Y J Clin Lab Immunol; 1983 Apr; 10(4):209-14. PubMed ID: 6602889 [TBL] [Abstract][Full Text] [Related]
37. [Cytochalasin B is an inhibitor of the cytotoxic activity of sensitized lymphoid cells]. Degiovanni G C R Seances Soc Biol Fil; 1972; 166(4):736-40. PubMed ID: 4631303 [No Abstract] [Full Text] [Related]
38. Specific adoptive therapy of established leukemia with syngeneic lymphocytes sequentially immunized in vivo and in vitro and nonspecifically expanded by culture with Interleukin 2. Cheever MA; Greenberg PD; Fefer A J Immunol; 1981 Apr; 126(4):1318-22. PubMed ID: 6970768 [No Abstract] [Full Text] [Related]
39. Immunoregulatory circuit among macrophage subsets for T cell-mediated cytotoxic response to tumor cells. Ting CC; Rodrigues D J Immunol; 1980 Mar; 124(3):1039-44. PubMed ID: 6444645 [No Abstract] [Full Text] [Related]
40. Lymphocyte population of AKR-J mice. II. Effect of leukemogenesis on migration patterns, response to PHA, and expression of theta antigen. Zatz MM; White A; Goldstein AL J Immunol; 1973 Nov; 111(5):1519-25. PubMed ID: 4744927 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]